An Overview of Young-Onset Parkinson's Disease - Clinical and Patient Perspectives


The cost for this online course is $20. The estimated time to complete this course is 60 minutes. Learners will be asked to complete an activity post-assessment with a passing score of 75%.

You must log in or create an account before enrolling in this educational activity. 

Once you register for the course, you will have 30 days from the date of enrollment to complete the course. The date your access expires will be indicated in the Course Summary box on this webpage.

Target Audience

Healthcare professionals.

Educational Need

Parkinson's Disease (PD) is a progressive disorder that causes central nervous system degeneration and unintended neuromuscular symptoms such as tremors, stiffness, and difficulty with balance and coordination. It is considered young-onset PD (YOPD) when the individual is younger than 50. While the clinical presentation is similar to late-onset PD, YOPD patients experience symptoms and take medications for longer, contributing to a significantly greater risk of developing dyskinesias and dystonias. They also often face unique financial, family, and employment challenges that are less frequently an issue than their late-onset counterparts.

A positive aspect of YOPD is that younger brains are more neuroplastic, which allows the brain to respond to treatment more effectively. Participation in specialized movement programs early in the disease progression can maintain and even improve the loss of central nervous system function. Cases of YOPD should be referred to movement specialists as early as possible to ensure the best functional outcome for these individuals. Healthcare providers must be competent in identifying YOPD and can promptly initiate treatment for their younger-adult patients.


  • Recognize the typical clinical presentation and special considerations related to YOPD.
  • Recall the most common pharmacological intervention for controlling YOPD and its side effects.
  • Describe the indications for Deep Brain Stimulation in the management of YOPD.
  • Explain the benefits and goals of exercise/movement-based interventions to improve symptoms and lessen the impact of the disease for individuals with YOPD.
  • Reflect on how the patient perspective impacts healthcare providers.


Allison Larson, PT, DPT, NCS
Assistant Professor, Doctor of Physical Therapy Program, Des Moines University


Danielle Horgen, MMS, PA-C
Assistant Professor, Master of Science in Physician Assistant Studies Program, Des Moines University


Kelsee Hove, OTD, OTR/L, CBIS, DRS
Director of Clinical Education and Assistant Professor, Doctor of Occupational Therapy Program, Des Moines University


Craig Haas
Vice President, Board of Directors Executive Committee, American Parkinson Disease Association Iowa Chapter
Individual Living With Young-Onset Parkinson's Disease

Terms of Use and Privacy Policy

Recording date: October 13, 2022
Date of original release: October 19, 2022
Most recent review/update: October 19, 2022
Termination date: October 18, 2025

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credits
  • 1.00 AOA Category 1­B
  • 1.00 CE Contact Hour(s)
  • 1.00 CPME
  • 1.00 IBON
Course opens: 
Course expires: 

Accreditation Statements

  • MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS). Des Moines University (DMU) is accredited by the IMS to provide continuing medical education for physicians. DMU designates this enduring materials activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.  Physicians should only claim credit commensurate with the extent of their participation in the activity.
  • DO: Des Moines University (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this activity for a maximum of 1.0 AOA Category 1-B credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
  • Nurse: Des Moines University is Iowa Board of Nursing approved provider #112. This activity has been reviewed and approved for 1.0 continuing education contact hour(s). No partial credit awarded.​
  • Other Healthcare Professionals: This enduring materials activity is designated for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.

Educational Grants

No ineligible company provided financial support for this continuing education activity. 


The planning committee member(s) and speaker(s) will disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). The determination of educational content and the selection of speakers is the responsibility of the activity director.

Relevant to the content of this educational activity, the following individual(s) have no conflict(s) with ineligible companies to disclose.

  • Craig Haas - Speaker
  • Danielle Horgen, MMS, PA-C - Speaker
  • Kelsee Hove, OTD, OTR/L, CBIS, DRS - Speaker
  • Allison Larson, PT, DPT, NCS - Speaker


The information provided in this activity is for continuing education. It is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The content of each presentation does not necessarily reflect the views of Des Moines University.

Available Credit

  • 1.00 AMA PRA Category 1 Credits
  • 1.00 AOA Category 1­B
  • 1.00 CE Contact Hour(s)
  • 1.00 CPME
  • 1.00 IBON


Please login or Create an Account to take this course.